Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Ordinary Shares, par value $0.000174
Shares outstanding: 55,833,616
Number of holders: 16
Total 13F shares, excl. options: 19,072,268
Shares change: +3,681,140
Total reported value, excl. options: $372,436,000
Value change: +$73,098,989
Number of buys: 8
Number of sells: -17
Price: $19.53

Significant Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) as of Q2 2021

29 filings reported holding CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 as of Q2 2021.
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,072,268 shares of 55,833,616 outstanding shares and own 34.16% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6,991,003 shares), FMR LLC (3,925,836 shares), BlackRock Inc. (2,458,132 shares), BOXER CAPITAL, LLC (2,081,323 shares), WELLINGTON MANAGEMENT GROUP LLP (1,532,718 shares), Cormorant Asset Management, LP (650,000 shares), RTW INVESTMENTS, LP (450,000 shares), JANUS HENDERSON GROUP PLC (391,339 shares), Octagon Capital Advisors LP (373,492 shares), and Old Well Partners, LLC (122,431 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.